Efficacy and Safety Study of Fluticasone Furoate (FF)/GW642444 Inhalation Powder and the Individual Components in Subjects With Chronic Obstructive Pulmonary Disease (COPD)

PHASE3CompletedINTERVENTIONAL
Enrollment

1,226

Participants

Timeline

Start Date

October 19, 2009

Primary Completion Date

February 1, 2011

Study Completion Date

February 8, 2011

Conditions
Pulmonary Disease, Chronic Obstructive
Interventions
DRUG

FF Inhalation Powder

Inhaled Corticosteroid (ICS)

DRUG

FF/GW642444 Inhalation Powder

Inhaled Corticosteroid (ICS)/ Long Acting Beta Agonist(LABA) for COPD

DRUG

GW642444 Inhalation Powder

Long Acting Beta Agonist(LABA)

DRUG

Placebo

Placebo

Trial Locations (149)

4000

GSK Investigational Site, San Miguel de Tucumán

7712

GSK Investigational Site, Ocean City

10117

GSK Investigational Site, Berlin

10367

GSK Investigational Site, Berlin

10717

GSK Investigational Site, Berlin

10787

GSK Investigational Site, Berlin

11229

GSK Investigational Site, Brooklyn

12043

GSK Investigational Site, Berlin

12203

GSK Investigational Site, Berlin

13086

GSK Investigational Site, Berlin

13125

GSK Investigational Site, Berlin

13581

GSK Investigational Site, Berlin

14057

GSK Investigational Site, Berlin

19055

GSK Investigational Site, Schwerin

19805

GSK Investigational Site, Wilmington

20902

GSK Investigational Site, Wheaton

21029

GSK Investigational Site, Vinnytsia

21502

GSK Investigational Site, Geesthacht

22143

GSK Investigational Site, Hamburg

22299

GSK Investigational Site, Hamburg

22335

GSK Investigational Site, Hamburg

22401

GSK Investigational Site, Fredericksburg

26505

GSK Investigational Site, Morgantown

27909

GSK Investigational Site, Elizabeth City

28625

GSK Investigational Site, Statesville

29118

GSK Investigational Site, Orangeburg

29203

GSK Investigational Site, Columbia

29303

GSK Investigational Site, Spartanburg

29340

GSK Investigational Site, Gaffney

29379

GSK Investigational Site, Union

29640

GSK Investigational Site, Easley

29678

GSK Investigational Site, Seneca

30907

GSK Investigational Site, Martinez

32503

GSK Investigational Site, Pensacola

32927

GSK Investigational Site, Cocoa

33316

GSK Investigational Site, Fort Lauderdale

33511

GSK Investigational Site, Brandon

33744

GSK Investigational Site, Bay Pines

33756

GSK Investigational Site, Clearwater

35235

GSK Investigational Site, Birmingham

35501

GSK Investigational Site, Jasper

37601

GSK Investigational Site, Johnson City

37825

GSK Investigational Site, New Tazewell

45231

GSK Investigational Site, Cincinnati

45439

GSK Investigational Site, Dayton

49051

GSK Investigational Site, Dnipropetrovsk

51069

GSK Investigational Site, Cologne

55624

GSK Investigational Site, Rhaunen

60389

GSK Investigational Site, Frankfurt am Main

60596

GSK Investigational Site, Frankfurt am Main

61035

GSK Investigational Site, Kharkiv

63301

GSK Investigational Site, Saint Charles

63571

GSK Investigational Site, Gelnhausen

64287

GSK Investigational Site, Darmstadt

65117

GSK Investigational Site, Odesa

66215

GSK Investigational Site, Lenexa

70000

GSK Investigational Site, Bucharest

70868

GSK Investigational Site, Ostrava - Poruba

73103

GSK Investigational Site, Oklahoma City

75110

GSK Investigational Site, Corsicana

76508

GSK Investigational Site, Temple

77339

GSK Investigational Site, Kingwood

78006

GSK Investigational Site, Boerne

80339

GSK Investigational Site, Munich

90048

GSK Investigational Site, Los Angeles

90404

GSK Investigational Site, Santa Monica

90712

GSK Investigational Site, Lakewood

90808

GSK Investigational Site, Long Beach

91754

GSK Investigational Site, Monterey Park

91950

GSK Investigational Site, National City

92120

GSK Investigational Site, San Diego

95043

GSK Investigational Site, Simferopol

97213

GSK Investigational Site, Portland

97504

GSK Investigational Site, Medford

105077

GSK Investigational Site, Moscow

127018

GSK Investigational Site, Moscow

153005

GSK Investigational Site, Ivanovo

193231

GSK Investigational Site, Saint Petersburg

194354

GSK Investigational Site, Saint Petersburg

300310

GSK Investigational Site, Timișoara

330160

GSK Investigational Site, Deva

400349

GSK Investigational Site, Cluj-Napoca

400371

GSK Investigational Site, Cluj-Napoca

420015

GSK Investigational Site, Kazan'

454106

GSK Investigational Site, Chelyabinsk

500112

GSK Investigational Site, Brasov

650000

GSK Investigational Site, Kemerovo

660022

GSK Investigational Site, Krasnoyarsk

700115

GSK Investigational Site, Iași

720284

GSK Investigational Site, Suceava

900002

GSK Investigational Site, Constanța

93030-5841

GSK Investigational Site, Oxnard

Unknown

GSK Investigational Site, Decatur

GSK Investigational Site, Gainesville

GSK Investigational Site, Yaroslavl

08003

GSK Investigational Site, Cherry Hill

74136-8303

GSK Investigational Site, Tulsa

R8324EMB

GSK Investigational Site, Cipolletti

C1121ABE

GSK Investigational Site, Buenos Aires

C1425BEN

GSK Investigational Site, Buenos Aires

625 00

GSK Investigational Site, Brno

377 01

GSK Investigational Site, Jindřichův Hradec

278 01

GSK Investigational Site, Kralupy nad Vltavou

460 01

GSK Investigational Site, Liberec

301 00

GSK Investigational Site, Pilsen

323 00

GSK Investigational Site, Pilsen

180 81

GSK Investigational Site, Prague

182 00

GSK Investigational Site, Prague

337 01

GSK Investigational Site, Rokycany

390 19

GSK Investigational Site, Tábor

01307

GSK Investigational Site, Dresden

04109

GSK Investigational Site, Leipzg

01445

GSK Investigational Site, Radebeul

296-8602

GSK Investigational Site, Chiba

791-0281

GSK Investigational Site, Ehime

811-3195

GSK Investigational Site, Fukuoka

306-0433

GSK Investigational Site, Ibaraki

602-8026

GSK Investigational Site, Kyoto

612-0026

GSK Investigational Site, Kyoto

514-1101

GSK Investigational Site, Mie

901-2132

GSK Investigational Site, Okinawa

904-2143

GSK Investigational Site, Okinawa

530-0001

GSK Investigational Site, Osaka

591-8555

GSK Investigational Site, Osaka

434-8511

GSK Investigational Site, Shizuoka

158-0083

GSK Investigational Site, Tokyo

42-200

GSK Investigational Site, Częstochowa

80-952

GSK Investigational Site, Gdansk

97-540

GSK Investigational Site, Gidle

11-500

GSK Investigational Site, Giżycko

41-940

GSK Investigational Site, Piekary Śląskie

71-124

GSK Investigational Site, Szczecin

01-138

GSK Investigational Site, Warsaw

02-097

GSK Investigational Site, Warsaw

18-400

GSK Investigational Site, Łomża

010816

GSK Investigational Site, Bucharest

011794

GSK Investigational Site, Bucharest

020125

GSK Investigational Site, Bucharest

020201

GSK Investigational Site, Bucharest

030317

GSK Investigational Site, Bucharest

031298

GSK Investigational Site, Bucharest

050159

GSK Investigational Site, Bucharest

077160

GSK Investigational Site, Popeşti-Leordeni

119 048

GSK Investigational Site, Moscow

03680

GSK Investigational Site, Kiev

01114

GSK Investigational Site, Kyiv

02091

GSK Investigational Site, Kyiv

03038

GSK Investigational Site, Kyiv

03115

GSK Investigational Site, Kyiv

Sponsors

Lead Sponsor

All Listed Sponsors
lead

GlaxoSmithKline

INDUSTRY

NCT01054885 - Efficacy and Safety Study of Fluticasone Furoate (FF)/GW642444 Inhalation Powder and the Individual Components in Subjects With Chronic Obstructive Pulmonary Disease (COPD) | Biotech Hunter | Biotech Hunter